p53-mediated repression of nuclear factor-κB RelA via the transcriptional integrator p300

Cancer Research

Volumn 58, Issue 20, 1998, Pages 4531-4536

  Ravi, Rajani ^a   Mookerjee, Bijoyesh ^a   Van Hensbergen, Yvette ^a   Bedi, Gauri C ^a   Giordano, Antonio ^b   El Deiry, Wafik S ^c   Fuchs, Ephraim J ^a   Bedi, Atul ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN P53;

ANIMAL CELL; ARTICLE; GENE OVEREXPRESSION; GENE REPRESSION; GENETIC TRANSCRIPTION; IMMUNOBLOTTING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RNA TRANSLATION; TRANSACTIVATION; TRANSCRIPTION REGULATION;

CREB-BINDING PROTEIN; DNA; GENES, P53; HUMANS; LIGASES; NF-KAPPA B; NUCLEAR PROTEINS; TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC;

EID: 0032532070     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Levine, A. J. p53, the cellular gatekeeper for growth and division. Cell, 88: 323-331, 1997.
2. Kern, S. E., Kinzler, K. W., Bruskin, A., Jarosz, D., Friedman, P., Prives, C., and Vogelstein, B. Identification of p53 as a sequence-specific DNA-binding protein. Science (Washington DC), 252: 1708-1711, 1991.
3. Ginsberg, D., Mechta, F., Yaniv, M., and Oren, M. Wild-type p53 can down-modulate the activity of various promoters. Proc. Natl. Acad. Sci. USA, 88: 9979-9983, 1991.
4. Lill, N. L., Grossman, S. R., Ginsberg, D., DeCaprio, J., and Livingston, D. M. Binding and modulation of p53 by p300/CBP coactivators. Nature (Lond.), 387: 823-827, 1997.
5. Gu, W., Shi, X. L., and Roeder, R. G. Synergistic activation of transcription by CBP and p53. Nature (Lond.), 387: 819-823, 1997.
6. Avantaggiati, M. L., Ogryzko, V., Gardner, K., Giordano, A., Levine, A. S., and Kelly, K. Recruitment of p300/CBP in p53-dependent signal pathways. Cell, 89: 1175-1184, 1997.
7. Somasundaram, K., and El-Deiry, W. S. Inhibition of p53-mediated transactivation and cell cycle arrest by ElA through its p300/CBP-interacting region. Oncogene, 14: 1047-1057, 1997.
8. Blagoskolonny, M. V., An, W. G., Romanova, L. Y., Trepel, J., Fojo, T., and Neckers, L. p53 inhibits hypoxia-inducible factor-stimulated transcription. J. Biol. Chem., 273: 11995-11998, 1998.
9. Gerritsen, M. E., Williams, A. J., Neish, A. S., Moore, S., Shi, Y., and Collins, T. CREB-binding protein/p300 arc transcriptional coactivators of p65. Proc. Natl. Acad. Sci. USA, 94: 2927-2932, 1997.
10. Perkins, N. D., Felzien, L. K., Betts, J. C., Leung, K., Beach, D. H., and Nabel, G. J. Regulation of NF-κB by cyclin-dependent kinases associated with the p300 coactivator. Science (Washington DC), 275: 523-527, 1997.
11. Baeuerle, P. A., and Baltimore, D. NF-κB: ten years after. Cell, 87: 13-20, 1996.
12. Wu, G. S., Burns, T. F., McDonald, E. R., Jiang, W., Meng, R., Krantz, I. D., Kao, G., Gan, D. D., Zhou, J. Y., Muschel, R., Hamilton, S. R., Spinner, N. B., Markowitz, S., Wu, G., and El-Deiry, W. S. KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene (letter). Nat. Genet., 17: 141-143, 1997.
13. Lowe, S. W., Ruley, H. E., Jacks, T., and Housman, D. E. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell, 74: 957-967, 1993.
14. Beg, A. A., Sha, W. C., Rronson, R. T., Ghosh, S., and Baltimore, D. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB. Nature (Lond.), 376: 167-170, 1995.
15. El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., and Vogelstein, B. WAFI, a potential mediator of p53 tumor suppression. Cell, 75: 817-825, 1993.
16. Beg, A. A., and Baltimore, D. An essential role for NF-κB in preventing TNF-α-induced cell death (see comments). Science (Washington DC), 274: 782-784, 1996.
17. Van Antwerp, D. J., Martin, S. J., Kafri, T., Green, D. R., and Verma, I. M. Suppression of TNF-α-induced apoptosis by NF-κB (see comments). Science (Washington DC), 274: 787-789, 1996.
18. Nabel, G., and Baltimore, D. An inducible transcription factor activates expression of human immunodeficiency virus in T cells. Nature (Lond.), 326: 711-713, 1987.
19. Ravi, R., Bedi, A., Fuchs, E. J., and Bedi, A. CD95 (Fas)-induced caspase-mediated proteolysis of NF-κB. Cancer Res., 58: 882-886, 1998.
20. Scheffner, M., Huibregtse, J. M., Vierstra, R. D., and Howley, P. M. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell, 75: 495-505, 1993.
21. Sun, S. C., Ganchi, P. A., Ballard, D. W., and Greene, W. C. NF-κB controls expression of inhibitor IκBα: evidence for an inducible autoregulatory pathway. Science (Washington DC), 259: 1912-1915, 1993.
22. Scott, M. L., Fujita, T., Liou, H. C., Nolan, G. P., and Baltimore, D. The p65 subunit of NF-κB regulates IκB by two distinct mechanisms. Genes. Dev., 7: 1266-1276, 1993.
23. Nakajima, T., Uchida, C., Anderson, S. F., Lee, C. G., Hurwitz, J., Parvin, J. D., and Montminy, M. RNA helicase A mediates association of CBP with RNA polymerase II. Cell, 90: 1107-1112, 1997.
24. Nolan, G. P., Ghosh, S., Liou, H. C., Tempst, P., and Baltimore, D. DNA binding and IκB inhibition of the cloned p65 subunit of NF-κB, a rel-related polypeptide. Cell, 64: 961-969, 1991.
25. Eckner, R., Ewen, M. E., Newsome, D., Gerdes, M., DeCaprio, J. A., Lawrence, J. B., and Livingston, D. M. Molecular cloning and functional analysis of the adenovirus E1A-associated 300-kD protein (p300) reveals a protein with properties of a transcriptional adaptor. Genes. Dev., 8: 869-884, 1994.
26. Shikama, N., Lyon, L., and La Thangue, N. B. The p300/CBP family: integrating signals with transcription factors and chromatin. Trends Cell. Biol., 7: 230-236, 1997.
27. Korzus, E., Torchia, J., Rose, D. W., Xu, L., Kurokawa, R., McInerney, E. M., Mullen, T. M., Glass, C. K., and Rosenfeld, M. G. Transcription factor-specific requirements for coactivators and their acetyltransferase functions. Science (Washington DC), 279: 703-707, 1998.
28. Gu, W., and Roeder, R. G. Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell, 90: 595-606, 1997.
29. Schule, R., and Evans, R. M. Cross-coupling of signal transduction pathways: zinc finger meets leucine zipper. Trends Genet., 7: 377-381, 1991.
30. Kamei, Y., Xu, L., Heinzel, T., Torchia, J., Kurokawa, R., Gloss, B., Lin, S. C., Heyman, R. A., Rose, D. W., Glass, C. K., and Rosenfeld, M. G. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell, 85: 403-414, 1996.
31. Yao, T., Oh, S. P., Fuchs, M., Zhou, N., Ch'ng, L., Newsome, D., Bronson, R. T., Li, E., Livingston, D. M., and Eckner, R. Gene-dosage-dependent embryonic development and proliferation defects in mice lacking the transcriptional integrator p300. Cell, 93: 361-372, 1998.
32. Wang, C. Y., Mayo, M. W., and Baldwin, A. S., Jr. TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-κB (see comments). Science (Washington DC), 274: 784-787, 1996.
33. Liu, Z. G., Hsu, H., Goeddel, D. V., and Karin, M. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-κB activation prevents cell death. Cell, 87: 565-576, 1996.
34. Mayo, M. W., Wang, C. Y., Cogswell, P. C., Rogers-Graham, K. S., Lowe, S. W., Der, C. J., and Baldwin, A. S., Jr. Requirement of NF-κB activation to suppress p53-independent apoptosis induced by oncogenic Ras. Science (Washington DC), 278: 1812-1815, 1997.